Verified email-pattern data for Combotope Therapeutics Aps is currently limited. You can still use the company insights and contact sections below.
Most of the current tumor-targeted antibodies only serve a subset of patients and a subset of cancers. Many of them also unintentionally target healthy tissues, causing severe side effects.
We aim to become the leading provider of truly tumor-specific monoclonal antibody (mAb) based therapies for all patients, for all cancer types, without targeting healthy cells.
Sugars (glycans) play a crucial role in modifying many essential proteins in our bodies, including those found on the surfaces of cancer cells. In most cancers, these sugar structures are shortened compared to healthy cells, offering a unique opportunity to differentiate between cancerous and normal cells.
Combotope Therapeutics has developed a proprietary mAb discovery platform designed to target cancer cells without impacting healthy cells. Our platform, known as integrated Design Antibody Libraries (iDEAL), combines glycan and peptide-focused scFv technology, providing antibodies that specifically target the tumor form of a particular protein on cancer cells while leaving healthy cells expressing the same, but correctly glycosylated protein, untouched. Our scFv sequences are of high affinity, making them suitable for easy integration into numerous therapeutic modalities for effective cancer treatment.
Our business model involves identifying, developing, and licensing proprietary scFv sequences that specifically target cancer proteins with aberrant O-glycosylation.
Through strategic partnerships, we will accelerate the development and commercialization of pioneering scFv-based off-the-shelf and personalized anti-cancer therapies.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Diplomvej 381, Lundtofte,capital Region Of Denmark 2800,denmark
- Industry
- Pharmaceutical Manufacturing
- Keywords
- Therapeutic antibody development, Oncology, mAb, Aberrant glycosylation, scFv, cancer, ADC, Bispecific, CAR-T cell, BiTE.
- HQ
- Lundtofte, Capital Region of Denmark
Combotope Therapeutics Aps Questions
Combotope Therapeutics ApS's website is http://www.combotopetherapeutics.com
Combotope Therapeutics ApS's LinkedIn profile is https://dk.linkedin.com/company/combotope-therapeutics-aps
Combotope Therapeutics ApS has
3 employees.
View email and phone details for 3
employees at Combotope Therapeutics ApS.
Combotope Therapeutics ApS's industry is
Pharmaceutical Manufacturing
Combotope Therapeutics ApS's top competitors are
2n Pharma,
Nanovi A/s,
Venomab,
Agrobiomics,
Pharmalex,
Venomaid Diagnostics,
Antag Therapeutics,
Monta Biosciences,
Adcendo,
Lead Biologics.
Combotope Therapeutics ApS's categories are Pharmaceutical Manufacturing
Combotope Therapeutics ApS's founding year is 2023
Explore related pages
Related company profiles:
Companies like Combotope Therapeutics ApS
Top Combotope Therapeutics ApS Employees
-
Ilknur Kasapoglu
🔬🧬Antibody Discovery Research…
Copenhagen, Capital Region Of Denmark, Denmark, Denmark -
Søren Nyboe Jakobsen
n/a
Copenhagen, Capital Region Of Denmark, Denmark, Denmark -
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records Ă— $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.